The P450s involved in xenobiotic metabolism are most highly expressed in the liver, but lower levels of selected P450 forms are also found in extrahepatic tissues such as the gastrointestinal tract, lung, kidney, olfactory epithelia, skin, and even the central nervous system.
The xenobiotic-metabolizing P450s are found within the CYP1, CYP2, CYP3, and CYP4 families. The CYP2 family is the most complex, having seven subfamilies in mammals; the regulation of these enzymes has been most extensively studied using the rat, mouse, and rabbit as model systems (3) (4) (5) (6) (9) . Certain genes are constitutively transcribed at low levels and can be up-regulated by ligand-dependent transcription factors such as those belonging to the nuclear receptor superfamily (10) or the basic helix-loophelix/PAS domain superfamily (6) . Tissue-specific expression of genes in the liver has been most actively studied. This is due in large part to the relative cellular homogeneity and easy accessibility of this tissue. Several families of transcription factors have been cloned from the liver and found to be preferentially expressed in this organ (11, 12) . These include HNF-la, HNF-1, HNF-3, HNF-4, C/EBPa, C/EBP, and DBP. In most cases, two or more factors are responsible for tissue-specific expression of a gene: an example would be the rat liver serum albumin gene, which is regulated by HNF-lct, C/EBPcx, C/EBP, and DBP (5) . This scenario appears to be the rule rather than the exception for liverspecific expression of genes. by binding to an upstream regulatory element such as that described for the rabbit gene (16) . Recent studies of the AHR knockout mice that lack expression of the receptor suggest that it also affects constitutive expression of CYP1A2 (17) . Levels of CYP1A2 mRNA are decreased more than 80% in the knockout compared to normal mice. Constitutive expression of the AHR-dependent UDP glucuronosyltransferase form 6 gene was also much lower in the AHR-deficient mice. The mechanism by which AHR, in the absence of an exogenous ligand, influences constitutive expression of genes is not known. One possibility is that an endogenous ligand exists that causes preferential binding of the AHRJARNT heterodimer to certain regulatory elements of target genes. It is not likely that a ligandless receptor influences gene expression, because in vitro the AHR only binds to DNA when ligand is bound and when the heterodimer is formed with ARNT (6). Another possibility is that the AHR influences expression of hepatocyte-enriched transcription factors that regulate numerous genes required for liver function. Indeed, the livers of AHR knockout mice are small relative to total body weight and exhibit a degree of portal tract fibrosis not seen in wildtype mice (17) .
CYP2E1
The CYP2E1 gene is constitutively expressed primarily in the liver. The protein can be detected in other tissues by chemically inducted diabetes or by chronic administration of inducers such as ethanol and acetone (18) . Induction of CYP2E1 by ethanol and acetone proceeds primarily via a posttranscriptional mechanism involving substrate-induced protein stabilization (19) . In the liver, CYP2E1 transcription commences within the first few hours after birth and reaches maximal levels by the age of 7 days (20) . In vitro transcription and trans-activation studies suggest that CYP2E1 is controlled in part by the liver-enriched factor HNF-la (21, 22 (22) . This is coincident with changes in cytosine methylation that correlate with developmental activation of the gene (24) . Indeed, methylation is known to be influenced by chromatin accessibility (25) .
CYP2C genes
The rat CYP2C6 gene is expressed in males and females at the unset of puberty between 4 and 6 wk of age. Its transcription correlates with developmental activation of the factor DBP, a protein identified as controlling adult liver-specific expression of the albumin gene (26) . DBP is able to bind to an element located just upstream of the CYP2C6 promoter and to activate transcription in a transactivation assay (27) . This element is quite distinct from that found upstream of the rat albumin gene; the latter can bind to and be activated by DBP, C/EBPcx, and C/EBP, whereas the CYP2C6 site binds all three factors but can only be activated by DBP. 
CYP2D5
A subfamily of four or five CYP2D genes exist in mice and rats (7) . Some of these genes are expressed in the liver and kidney. In rats, methylation of certain cytosine residues correlates with differences in the developmental activation of CYP2D3 and CYP2D5 in the liver seen after birth (35 A possible mechanism by which C/EBP and Spi interact to control the CYP2D5 promoter is depicted in Fig. 1 . In the absence of Spi, C/EBP is unable to bind to its recognition sequence.
In the presence of Spi alone, a low level of transcription is possible whereas in the presence of both factors, higher rates of transcription are achieved through interaclion with the TATA box-associating factor TAF,10 and possibly another unconfirmed TAF member.
SEX-SPECIFIC EXPRESSION OF P450 GENES

Cyp2d9
The mouse cyp2d9 gene is expressed in a sex-specific manner in the liver and kidney of the domestic laboratory mouse Musmusculus domesticus. The CYP2D9 is specifically expressed in male mice; a cis-acting element upstream of the cyp2d9 gene, designated SD! (sex difference information), contains a CpG site that is preferentially demethylated in males (37, 38) . A related site is found upstream of the cyp2a4 gene that is preferentially expressed in females (38) . In this case, the site is demethylated in females. The SDI element is also shared by another gene encoding a duplicate of compliment C4, designated sip, that is expressed in male mice (39) . The sip gene SDI is demethylated in males, whereas in the natural C4 gene, which is expressed in both sexes, the CpG is demethylated in both male and female mice.
Two DNA binding factors, GABP ct/n heterodimer and NF2d9, were purified by DNA sequence affinity chromatography using the cyp2d9 SD! sequence (38, 40) . These factors display distinct but overlapping binding sites. Both factors can interact with the SD! sequence.
GABP does not bind to the methylated CpG at position -97 within the SDI sequence (38), whereas NF2d9 is sensitive to the T/C base change at position -99 within the SD! (40) .
GABP is expressed in tissues other than the liver and kidney, which are the primary sites of cyp2d9 expression, and is known to bind to crs elements in other more ubiquitously expressed genes such as those encoding ribosomal and mitochondrial proteins (41) . NF2d9 is closely related to human LBP-lcx, a transcription modulator of the H!V-1 promoter (38, 42) . Like GABP, NF2d9 protein is found in tissues other than the liver and kidney, and is expressed in both sexes and not preferentially in males, as is cyp2d9. !n addition, NF2d9 may be required to interact with other factors or to undergo a secondary modification, such as phosphotylation, in order to bind to the SD! element, because recombinant NF2d9 does not directly bind to the SD! sequence (40) .
GABP is a potential transcriptional activator of the malespecific cyp2d9 promoter, as determined by trans-activation transfection assays in HepG2 cells (38) . On the other hand, the functional role of the NF2d9 protein on the male-specific CYP2D9 promoter has not been determined.
It remains to be
The Spi-binding established whether GABP or NF2d9, or both, play a major role in male-specific expression of cyp2d9 in Mus domesticus. Tissue-and sex-specific expression of neither factor correlates with expression of cyp2d9. Perhaps chromatin structure and/or methylation patterns determine the tissuespecific expression patterns. Indeed, methylation does correlate with cyp2d9 transcription, and GABP DNA binding is methylation sensitive (37, 38) . Sex-specific expression of P450 genes is known to be under the control of growth hormone secretory patterns (43) . These patterns are neonatally imprinted by androgens. At present, it is unclear whether growth hormone controls the male-specific expression of cyp2d9.
Growth hormone-mediated P450 gene control
Recent studies suggest that the factor STAT 5 or a STAT-related factor is involved in growth hormone-mediated, malespecific gene expression in the rat (44) . STATs are a family of DNA binding proteins that mediate gene expression through cell-surface receptors that bind to growth factors and cytokines (15) . Upon ligand binding, the cytokine receptors cause the induction of tyrosine phosphoiylation by members of the Janus kinase superfamily (JAKs). JAKs autophosphorylate, phosphorylate the cell-surface cytokine receptors, and phosphorylate STATs. Three JAKs are known and are associated with specific receptors. Phosphorylation of STATs results in activating their ability to translocate to the nucleus, where they bind to cis elements and stimulate gene transcription (15) .
!n male rats, a protein that was related to STAT 5 is specifically tyrosine phosphorylated (44) . This protein was also phosphorylated and translocated to the nucleus by the pulsatile male pattern of growth hormone secretion. In contrast, continuous female patterns of secretion resulted in no phosphorylation and an actual desensitization to phosphotylation.
CYP3A1O
The hamster CYP3A1O gene is preferentially expressed in males and contains a cis element capable of binding to activated STAT proteins (45) gene is preferentially expressed in female rats and is dependent on the low-level but constant growth hormone secretory pattern exhibited by this sex. This pattern can be mimicked in primary cultures of hepatocytes, resulting in substantial CYP2C12 expression (46) . Using hepatocyte cultures, a role for cPLA2 in CYP2CJ2 expression was recently defined (47) . cPLA2 is downstream of a cascade of events that are stimulated by several cytokines involving rave, MAP kinase kinase, and MAP kinase (48, 49) . cPLA2 is phosphorylated and activated to a form that can be physically defined by a lower mobility on SDS-PAGE.
Under conditions used to express CYP2C12, growth hormone was able to stimulate activation of cPLA2 or a protein bearing structural similarity to this lipase (46) . Concurrently, arachidonic acid was liberated from cellular phospholipids. This release was potentiated by calcium mobilization. Further evidence suggests that epoxides (or an expoxide) of arachidonic acid are the terminal products of the cascade leading to increased CYP2C12 expression.
These epoxides are likely generated through a P450-mediated reaction.
A summary of the role of cell-surface growth hormone receptors in control of P450 gene expression is shown in Fig.  2 . It appears likely that both STAT and cPLA2 activation mediate the sex-dependent expression of P450s in rats. Perhaps one pathway stimulates one set of P450 genes and another pathway stimulates expression of other P450 genes. Alternatively, it is possible that both pathways act on different genes, in some cases activating and in other cases inhibiting expression.
These possibilities await further experimentation.
